Literature DB >> 12677449

Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease.

Yuri Trembath1, Carolyn Rosenberg, John F Ervin, Donald E Schmechel, Perry Gaskell, Margaret Pericak-Vance, Jeffery Vance, Christine M Hulette.   

Abstract

Our institution is currently engaged in ongoing genetic studies of familial Alzheimer's disease (AD), which include clinical ascertainment and brain autopsy of both affected and non-affected family members. Here we describe the analysis of 22 AD families, each with at least one family member with a postmortem diagnosis of dementia with Lewy bodies (DLB). For this study, 47 brains were examined according to NINCDS-Reagan Institute criteria for the diagnosis of AD. Lewy body pathology was evaluated with alpha-synuclein immunohistochemistry. Four families, with either one or two autopsies showing Lewy body pathology, demonstrated linkage to 12p. Five families had two or more autopsies with Lewy body pathology, but their linkage status was unknown. The remaining 13 families had one autopsy demonstrating Lewy bodies. These findings suggest that at least one pathological form of DLB may be familial. In some families, the pathological phenotype is identical in all examined affected family members; but in others, there may be several pathologies that coexist. Careful neuropathological examination of affected family members may prove critical for future genetic analysis of AD and DLB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12677449     DOI: 10.1007/s00401-003-0670-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  12 in total

1.  Association between male gender and cortical Lewy body pathology in large autopsy series.

Authors:  Peter T Nelson; Frederick A Schmitt; Gregory A Jicha; Richard J Kryscio; Erin L Abner; Charles D Smith; Linda J Van Eldik; William R Markesbery
Journal:  J Neurol       Date:  2010-06-20       Impact factor: 4.849

2.  Untangling a role for tau in synucleinopathies.

Authors:  Marion Delenclos; Simon Moussaud; Pamela J McLean
Journal:  Biol Psychiatry       Date:  2015-11-15       Impact factor: 13.382

3.  Cerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease.

Authors:  Christine M Hulette; John F Ervin; Yvette Edmonds; Samantha Antoine; Nicolas Stewart; Mari H Szymanski; Kathleen M Hayden; Carl F Pieper; James R Burke; Kathleen A Welsh-Bohmer
Journal:  J Neuropathol Exp Neurol       Date:  2009-04       Impact factor: 3.685

4.  Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?

Authors:  Manfred Windisch; Birgit Hutter-Paier; Edith Schreiner; Robert Wronski
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

5.  Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.

Authors:  Tetyana Duka; Valeriy Duka; Jeffrey N Joyce; Anita Sidhu
Journal:  FASEB J       Date:  2009-04-15       Impact factor: 5.191

6.  Low sensitivity in clinical diagnoses of dementia with Lewy bodies.

Authors:  Peter T Nelson; Gregory A Jicha; Richard J Kryscio; Erin L Abner; Frederick A Schmitt; Gregory Cooper; Li O Xu; Charles D Smith; William R Markesbery
Journal:  J Neurol       Date:  2009-10-01       Impact factor: 4.849

7.  Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies.

Authors:  P T Nelson; R J Kryscio; G A Jicha; E L Abner; F A Schmitt; L O Xu; G Cooper; C D Smith; W R Markesbery
Journal:  Neurology       Date:  2009-10-06       Impact factor: 9.910

Review 8.  Interaction between α-synuclein and other proteins in neurodegenerative disorders.

Authors:  Kurt A Jellinger
Journal:  ScientificWorldJournal       Date:  2011-10-24

9.  Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.

Authors:  Bidisha Roy; George R Jackson
Journal:  Hum Mol Genet       Date:  2014-01-14       Impact factor: 5.121

Review 10.  Consequences of post-translational modifications on amyloid proteins as revealed by protein semisynthesis.

Authors:  Stuart P Moon; Aaron T Balana; Matthew R Pratt
Journal:  Curr Opin Chem Biol       Date:  2021-06-25       Impact factor: 8.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.